Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

CI Global Asset Management Announces September 2023 Distributions for CI ETFs
CI Global Asset Management Announces September 2023 Distributions for CI ETFs


CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month or quarter ending September 30, 2023 in respect of the CI ETFs. In all cases, the distribution

Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder
Vistagen Announces Positive Results from Exploratory Phase 2A Study of PH80 for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

OSE Immunotherapeutics Announces: Positive Phase 3 Data from its Cancer Vaccine in Lung Cancer Patients with Resistance to Previous Immunotherapy Published in Annals of Oncology
OSE Immunotherapeutics Announces: Positive Phase 3 Data from its Cancer Vaccine in Lung Cancer Patients with Resistance to Previous Immunotherapy Published in Annals of Oncology


Regulatory News:



OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) (Paris:OSE) today announced the peer-reviewed publication in Annals of Oncology* of the randomized Phase 3 clinical

Fuel Tech to Present at 25th Annual H.C. Wainwright Global Investment Conference
Fuel Tech to Present at 25th Annual H.C. Wainwright Global Investment Conference


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen’s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan
Vistagen and Fuji Enter Exclusive Negotiation Agreement for a Potential License to Develop and Commercialize Vistagen’s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan


Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous system

CI Global Asset Management Brings Leading Alternative Asset Managers to Canadian Investors Through Two Private Markets Solutions
CI Global Asset Management Brings Leading Alternative Asset Managers to Canadian Investors Through Two Private Markets Solutions


CI Global Asset Management (“CI GAM”) announces two solutions that provide Canadian investors with access to unique investment opportunities in global private markets. The solutions, a growth

CI Financial Reports Total Assets of $430.3 Billion for July 2023
CI Financial Reports Total Assets of $430.3 Billion for July 2023


CI Financial Corp. (“CI”) (TSX: CIX) today reported preliminary total assets of $430.3 billion as at June 30, 2023, consisting of asset management assets of $123.7 billion, Canadian wealth

Vistagen Appoints Cindy Anderson as Chief Financial Officer
Vistagen Appoints Cindy Anderson as Chief Financial Officer


Vistagen (NASDAQ: VTGN) a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

Granite REIT Declares Distribution for August 2023
Granite REIT Declares Distribution for August 2023


Granite Real Estate Investment Trust (“Granite”) (TSX: GRT.UN / NYSE: GRP.U) announced today that its board of trustees has declared a distribution of CDN $0.2667 per stapled unit for the month of

Mannatech Reports Second Quarter End 2023 Financial Results
Mannatech Reports Second Quarter End 2023 Financial Results


Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of

EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter
EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter
EQS-News: Medios AG: achieves further growth in the first half of 2023 and expects strong third quarter
Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and Reports Fiscal 2024 First Quarter Financial Results
Subsequent to the Release of Positive Phase 3 Trial Results, Vistagen Provides Corporate Update and Reports Fiscal 2024 First Quarter Financial Results


Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression, and other central nervous

CI Financial Reports Financial Results for the Second Quarter of 2023
CI Financial Reports Financial Results for the Second Quarter of 2023


CI Financial Corp. (“CI”) (TSX: CIX) today released financial results for the quarter ended June 30, 2023.



“The second quarter was marked by several significant accomplishments across our

CI Financial to Acquire Ultra-High-Net-Worth Wealth Manager Coriel Capital
CI Financial to Acquire Ultra-High-Net-Worth Wealth Manager Coriel Capital


CI Financial Corp. (“CI”) (TSX: CIX) and Coriel Capital Inc. (“Coriel”) today announced an agreement under which CI will acquire Coriel, a Montreal-based wealth management firm.



Coriel, a firm

EQS-News: HelloFresh SE achieves its highest ever adjusted EBITDA of €192 million in second quarter of 2023
EQS-News: HelloFresh SE achieves its highest ever adjusted EBITDA of €192 million in second quarter of 2023
EQS-News: HelloFresh SE achieves its highest ever adjusted EBITDA of €192 million in second quarter of 2023
Granite Announces Second Quarter 2023 Results and the Issuance of its 2022 Global ESG+R Report
Granite Announces Second Quarter 2023 Results and the Issuance of its 2022 Global ESG+R Report


Granite Real Estate Investment Trust and Granite REIT Inc. (TSX: GRT.UN; NYSE: GRP.U) (“Granite” or the “Trust”) announced today its combined results for the three and six month periods ended June

Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023
Vistagen To Report First Quarter Financial Results and Host Corporate Update Conference Call on August 10, 2023


Vistagen (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

Fuel Tech Reports 2023 Second Quarter Financial Results
Fuel Tech Reports 2023 Second Quarter Financial Results


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder
Vistagen Announces Positive Top-Line Results from Phase 3 PALISADE-2 Trial of Fasedienol (PH94B) Nasal Spray in Social Anxiety Disorder


Vistagen (NASDAQ: VTGN), a clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system

Fuel Tech Awarded Air Pollution Control Orders Totaling $2.2 Million
Fuel Tech Awarded Air Pollution Control Orders Totaling $2.2 Million


Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and

Mitsui Chemicals Catalysis Science Awards 2024
Mitsui Chemicals Catalysis Science Awards 2024


Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: HASHIMOTO Osamu) gab heute bekannt, dass Online-Bewerbungen für die Mitsui Chemicals Catalysis Science Awards 2024 ab dem 1. September 2023

Mitsui Chemicals Catalysis Science Awards 2024
Mitsui Chemicals Catalysis Science Awards 2024


Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: HASHIMOTO Osamu) gab heute bekannt, dass Online-Bewerbungen für die Mitsui Chemicals Catalysis Science Awards 2024 ab dem 1. September 2023

Mitsui Chemicals Catalysis Science Awards 2024
Mitsui Chemicals Catalysis Science Awards 2024


Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: HASHIMOTO Osamu) gab heute bekannt, dass Online-Bewerbungen für die Mitsui Chemicals Catalysis Science Awards 2024 ab dem 1. September 2023

Mitsui Chemicals Catalysis Science Awards 2024
Mitsui Chemicals Catalysis Science Awards 2024


Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: HASHIMOTO Osamu) gab heute bekannt, dass Online-Bewerbungen für die Mitsui Chemicals Catalysis Science Awards 2024 ab dem 1. September 2023

Mitsui Chemicals Catalysis Science Awards 2024
Mitsui Chemicals Catalysis Science Awards 2024


Mitsui Chemicals, Inc. (Tokio: 4183; Präsident und CEO: HASHIMOTO Osamu) gab heute bekannt, dass Online-Bewerbungen für die Mitsui Chemicals Catalysis Science Awards 2024 ab dem 1. September 2023